Genetic factors affecting drug disposition in Asian cancer patients

作者: Nicholas Li-Xun Syn , Wei-Peng Yong , Soo-Chin Lee , Boon-Cher Goh

DOI: 10.1517/17425255.2015.1108964

关键词:

摘要: Introduction: In the era of genomic medicine, it is increasingly recognized that ethnogeographic differences in drug pharmacology exist between Asian and other populations. This particularly pertinent to oncology, where drugs forming backbone chemotherapy often have narrow therapeutic windows are frequently dosed close maximally tolerable levels.Areas covered: At population level, ancestry important because historical–biogeographical confluences shaped genetics pharmacoethnicity race through allelic differentiation interethnic inheritance patterns linkage disequilibrium. individual cis- trans-acting germline polymorphisms somatic mutations genes encoding drug-metabolizing enzymes transporters act a multifactorial manner determine disposition phenotype clinical response cancer patients. A growing body evidence also finds complex genetic interactions regulation, inc...

参考文章(97)
Guido Barbujani, Antti Sajantila, Oscar Lao, Jukka Corander, Johanna Sistonen, Silvia Fuselli, CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenetics and Genomics. ,vol. 17, pp. 93- 101 ,(2007) , 10.1097/01.FPC.0000239974.69464.F2
Joanne S. L. Lim, Xiang A. Chen, Onkar Singh, Yoon S. Yap, Raymond C. H. Ng, Nan S. Wong, Mabel Wong, Edmund J. D. Lee, Balram Chowbay, Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. British Journal of Clinical Pharmacology. ,vol. 71, pp. 737- 750 ,(2011) , 10.1111/J.1365-2125.2011.03905.X
S.M. de Morais, G.R. Wilkinson, J. Blaisdell, K. Nakamura, U.A. Meyer, J.A. Goldstein, The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. Journal of Biological Chemistry. ,vol. 269, pp. 15419- 15422 ,(1994) , 10.1016/S0021-9258(17)40694-6
C. Balram, Qingyu Zhou, Yin Bun Cheung, Edmund J. D. Lee, CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations. European Journal of Clinical Pharmacology. ,vol. 59, pp. 123- 126 ,(2003) , 10.1007/S00228-003-0594-2
Janine M. Morsman, Bertrand Rochat, Howard L. McLeod, Graeme I. Murray, William D. Figg, Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? Journal of Pharmacology and Experimental Therapeutics. ,vol. 296, pp. 537- 541 ,(2001)
Mayumi Saeki, Yoshiro Saito, Takahiro Nakamura, Norie Murayama, Su-Ryang Kim, Shogo Ozawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Toshiharu Nakajima, Hirohisa Saito, Yutaka Kitamura, Naoyuki Kamatani, Jun-ichi Sawada, Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population. Human Mutation. ,vol. 21, pp. 653- 653 ,(2003) , 10.1002/HUMU.9147
A V Khrunin, A Moisseev, V Gorbunova, S Limborska, Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients Pharmacogenomics Journal. ,vol. 10, pp. 54- 61 ,(2010) , 10.1038/TPJ.2009.45
Margaret-Mary Ameyaw, Fernando Regateiro, Tao Li, Xiehe Liu, Mohammed Tariq, Abeer Mobarek, Nadia Thornton, Gbolahan O. Folayan, Jessie Githang'a, Anne Indalo, David Ofori-Adjei, David A. Price-Evans, Howard L. McLeod, MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics. ,vol. 11, pp. 217- 221 ,(2001) , 10.1097/00008571-200104000-00005
Yali Xue, Donglin Sun, Allan Daly, Fengtang Yang, Xue Zhou, Mengyao Zhao, Ni Huang, Tatiana Zerjal, Charles Lee, Nigel P. Carter, Matthew E. Hurles, Chris Tyler-Smith, Adaptive Evolution of UGT2B17 Copy-Number Variation American Journal of Human Genetics. ,vol. 83, pp. 337- 346 ,(2008) , 10.1016/J.AJHG.2008.08.004